$CRIS

Curis Inc

  • NASDAQ
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Biological Product (except Diagnostic) Manufacturing

PRICE

$1.04 โ–ฒ10.615%

Last Close

VOLUME

1,922,723

DAY RANGE

0.91 - 1.05

52 WEEK

0.7 - 9.04

Join Discuss about CRIS with like-minded investors

profile
@Alpha #decarolis
recently

Cris, per favore evitiamo commenti sulle news... riporto semplicemente quelle che appaiono senza alcun commento aggiunto! Nulla in ciรฒ che accade fa ridere!!!

141 Replies 8 ๐Ÿ‘ 15 ๐Ÿ”ฅ

profile
@Alpha #decarolis
recently

Sembra Cris che ti auguri che l'Ucraina soccomba e che Putin trionfi. Incredibile!

86 Replies 10 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@Mago.del.Borneo #decarolis
recently

infatti cris... quel pare alludeva a un dubbio... speriamo davvero sia una fake

148 Replies 9 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@Alpha #decarolis
recently

Certamente Cris.. non lo metto in dubbio, ma resta il fatto che tatticamente ha fatto il suo effetto, non sulla popolazione ma altrove.

103 Replies 8 ๐Ÿ‘ 14 ๐Ÿ”ฅ

profile
@Roberto_88 #decarolis
recently

buongiorno a tutti!!! immagino la paura ma l'importante รจ che stiate tutti bene cris sia tu che Stefano e gli altri!

46 Replies 12 ๐Ÿ‘ 9 ๐Ÿ”ฅ

MA
@Max69 #decarolis
recently

giorno Cris

74 Replies 15 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@Massimo74 #decarolis
recently

de te non me fido, parlavo con CRIS

113 Replies 8 ๐Ÿ‘ 14 ๐Ÿ”ฅ

profile
@AntonioMangano #decarolis
recently

Cris รจ romano @Alpha :D

54 Replies 12 ๐Ÿ‘ 14 ๐Ÿ”ฅ

profile
@Alpha #decarolis
recently

Cris รจ toscano e non ci piove.... ma Stefano per caso รจ marchigiano?

118 Replies 15 ๐Ÿ‘ 11 ๐Ÿ”ฅ

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Upside momentum continues with S&P futures edging higher, looking to make it a 9th straight day of gains overall, and the Nasdaq Composite looking at an 11th straight day of advances, with no signs of caution by investors heading into key inflation data today and tomorrow. The producer price index (PPI) for October is expected at 8:30 AM, and the consumer price index (CPI) tomorrow, but still no concerns exhibited in the bond market with the 10-year yield at its lowest level in 2-weeks around 1.45%, while gold prices are steady at $1,829 an ounce. The S&P 500 closed at an all-time high for the eighth consecutive session last night, extending the longest winning streak since 1997, as investors added the impact of $1 trillion in fresh government stimulus. That coupled with removed travel lockdowns, a strong earnings season, and positive vaccine news has boosted stocks over the last month. In Asian markets, The Nikkei Index fell -0.75% to 29.285, the Shanghai Index gained 0.24% to settle at 3,507 and the Hang Seng Index rose 0.2% to 24,813. In Europe, the German DAX is up 45 points to 16,090, while the FTSE 100 rise 0.2% to 7,313. Stocks keep pushing higher, making new all time highs each day the past week for the Dow, Nasdaq, S&P 500 and Russell 2000. Events Calendar for Today 6:00 AM ET NFIB Small Business Optimism Index for Oct 7:45 AM ET ICSC Weekly Retail Sales 8:30 AM ET Producer Price Index MoM for Octoberโ€ฆest. 0.6% 8:30 AM ET Producer Price Index YoY for Octโ€ฆest. 8.7% 8:30 AM ET PPI Ex: Food & Energy MoM for Octoberโ€ฆest. 0.5% 8:30 AM ET PPI Ex Food & Energy YoY for Octoberโ€ฆest. 6.8% 8:55 AM ET Johnson/Redbook Weekly Sales 4:30 PM ET API Weekly Inventory Data Earnings Calendar: Earnings Before the Open: AFI, AGEN, APRN, BSY, CAH, CCO, CEVA, CNCE, CORR, CSII, CTG, DRNA, EBIX, ECOM, FSS, HAE, HAIN, HCI, HGV, HRMY, IGT, IIVI, ITCI, KPLT, MIDD, MRNS, MRSN, MSGE, OCGN, OSG, OWL, PLTR, PRPL, PRTY, SEAS, SSTI, STWD, SYY, TGI, VCEL, WHF, WKHS, WNC, WRK, XPEL Earnings After the Close: ACHV, AIRG, ALTO, ARLO, ASH, AVID, AXON, CALA, CCXI, CLPT, CNNE, COIN, CPRX, CPSI, CRIS, DAR, DASH,DNUT, DOCS, DSP, DV, EGAN, ELY, EPAY, EPM, EVBG, FC, FGEN, FLGT, FUBO, G, GO, HCKT, HYLN, ID, INO, KODK, LAW, LGND, LPRO, MCFE, MNKD, MODN, NVTS, OCX, ORGO, PAR, PAY, PAYS, PLUG, POSH, PUBM, PXLW, REI, RNG, RPAY, SAIL, SCSC, SEER, SGMS, SILK, SKIN, TMDX, TWNK, TWOU, U, UPST, VERI, VRM, VZIO, WES, WYNN Other Key Events: Baird 51st Annual Global Industrial Conference, 11/9-11/12 (virtual) Bank America 2021 Banking & Financials Conference, 11/9-11/10 (virtual) Cowen 7th Annual Software Bus Tour, 11/9/110 (virtual) Credit Suisse 30th Annual Healthcare Conference, 11/8-11/11 (virtual) JPMorgan Global Consumer, Retail & Luxury Conference, 11/8-11/11 (virtual) EEI Financial Conference, 11/7-11/9 (virtual) REITWorld 2021 Annual Conference, 11/9-11/12 (virtual) China PPI, CPI and M2 Money Supply for October Sector News Breakdown Consumer AMC Entertainment ($AMC) Q3 EPS ($0.44) vs est. ($0.53) on revenue $763.2M vs est. $708.3M; currently has liquidity availability over $1.8B, does not anticipate the need to borrow under revolver lines over the next 12 months CarLotz ($LOTZ) 3Q EPS ($0.03) vs est. ($0.21) on revs $68Mm vs est. $55.2Mm, will continue to open new hubs in 2022, though fewer than in 2021; says expects sequential qtrly improvement in retail units sold and retail GPU in 4Q Clarus Corp ($CLAR) 3Q adj EPS $0.50 vs est. $0.48 on sales $109Mm vs est. $106.1Mm; guides FY sales $362.5Mm vs est. $359.7Mm Freshpet ($FRPT) shares fell -14%; Q3 EPS (5c) vs est. 7c profit on revenue $107.6M vs est. $115.5M; now sees FY sales approx. $445M from prior guidance of sales exceeding $445M, adj EBITDA approx. $50M from prior view above $61M Hertz ($HTZZ)5M share Secondary priced at $29.00 R. Horton ($DHI) Q4 EPS $3.70 vs. est. $3.40; Q4 revs $8.1B vs. est. $7.94B; consolidated pre-tax profit margin improved 480 basis points to 21.3% and consolidated pre-tax income increased 63% to $1.7B; Q4 net sales orders down 33% to 15,949 homes; sees FY22 revenue $32.5B-$33.5B above consensus $32.22B International Flavors & Fragrances Inc. ($IFF) Q3 EPS $1.47 vs. est. $1.16; Q3 revs $3.07B vs. est. $2.61B; sees FY21 revs $11.55B vs. est. $10B; sees FY21 adjusted operating EBITDA margin 21% Inter Parfums ($IPAR) Q3 EPS $1.20 vs. est. $0.68; Q3 revs $263M vs. est. $262.69M; said our largest brands, notably Montblanc, Jimmy Choo, Coach, GUESS and Lanvin performed exceptionally well in the Q3 turning in gains of 26%, 40%, 98%, 27%, and 37%, respectively, as compared to 2019โ€™s third quarter Jack Henry Associates ($JKHY) 1Q EPS $1.38 vs est. $1.32 on revs $488.1Mm vs est. $489.4Mm; guides FY adj revs $1.87-1.875B vs est. $1.91B, sees FY EPS $4.64-4.73 vs est. $4.59 Masonite ($DOOR) 3Q adj EPS $1.99 vs est. $1.87 on revs $652Mm vs est. $675Mm; guides FY adj EPS $7.95-8.25 vs est. $8.13, sees FY sales +15-17% vs est. +18.6% RealReal ($REAL) Q3 adj EPS ($0.47) vs est. ($0.50) on revenue $119M vs est. $113.3M, adj EBITDA ($31.5M) vs est. ($36M), gross profit per order $94 vs $90 YoY, GMV $368M was +50% vs 2020 and +46% vs 2019, orders 757k (+38% YoY) ThredUp ($TDUP) 3Q EPS ($0.15) vs est. ($0.16) on revs $63.3Mm vs est. $61.8Mm, qtrly active buyers 1.4Mm and orders 1.3Mm (+14% and 28%, respectively); guides 4Q revs $69-71Mm vs est. $62.8Mm Trex Company ($TREX) Q3 EPS $0.64 vs. est. $0.58; Q3 revs $336M vs. est. $325.6M; guides Q4 revs $295M-$305M vs. est. $276.3M; Net income grew 73% to $74M; diluted earnings per share of $0.64, up 73%; EBITDA grew 76% to $108M; EBITDA margin of 32.2% Energy, Industrials and Materials General Electric ($GE) to split into three public companies โ€“ GE Aviation, GE Healthcare, and the combined GE Renewable Energy, GE Power, and GE Digital businesses to become three industry-leading, global, investment-grade public companies Advanced Energy Industries, Inc. ($AEIS) Q3 adj EPS $0.89 vs. est. $0.82; Q3 revs $346.1M vs. est. $341.52M; sees Q4 adj EPS 92c plus/minus 25c vs. est. $1.12; sees Q4 revs $355M plus/minus $20M vs. est. $373.09M. Amyris, Inc. ($AMRS) shares fell -25%; 3Q adj EPS ($0.27) vs est. ($0.15) on revs $48Mm vs est. $64.2Mm; sees FY revs $330-370Mm vs est. $391.6Mm; says supply chain challenges impacting near-term performance and growth trajectory Cabot ($CBT) Q4 adj EPS $1.01 vs. est. $1.03; Q4 revs $904M vs. est. $915.01M; Q4 Reinforcement Materials led the way delivering an increase in EBIT of $167 million while Performance Chemicals also recorded strong results; sees FY22 EPS $5.20-$5.60 vs. est. $5.52 Virgin Galactic ($SPCE) Q3 EPS loss (-$0.32) vs. est. loss (-$0.28); Q3 revs $2.6M vs. est. $1.6M; commercial service on track for q4 2022; strong ticket sales at updated pricing of $450,000 per seat; cash position remains strong at approximately $1.0 billion Financials CoreCivic, Inc. ($CXW) Q3 adj FFO/share $0.48, adj EPS $0.28 vs est. $0.18, revenue $471.2M vs est. $467.1M, adj EBITDA $100.9M vs est. $85.3M; is not providing full-year guidance due to uncertainties surrounding the resurgence of Covid-19 caused by the Delta variant and the administrationโ€™s executive actions and policies related to immigration and criminal justice, but will provide FY22 guidance in February when reporting 4Q21 results Cohen & Steers, Inc. ($CNS) preliminary assets under management of $101.6 billion as of October 31, 2021, an increase of $4.3 billion from assets under management at September 30, 2021. The increase was due to net inflows of $138 million and market appreciation of $4.4 billion, partially offset by distributions of $203 million. First Advantage ($FA) files to sell 15M shares of common stock for holders Lemonade Inc. ($LMND) will acquire Metromile in an all-stock transaction that implies a fully diluted equity value of approximately $500 million, or just over $200 million net of cash PayPal ($PYPL) Q3 non-GAAP EPS $1.11 vs. est. $1.07; Q3 revs $6.18B vs. est. $6.23B; Q3 total payment volume of $310B, growing 26%, and 24% on an FX-neutral basis; 4.9 billion payment transactions in qtr, up 22%; expects to add about 55Mm NNAs, including about 3 million active accounts from the acquisition of Paidy; 13.3M NNAs added in qtr , bringing total active accounts to 416 million, up 15%; expects FY TPV growth to be in the range of about 33%-34% at current spot rates and about 31%-32% on an FX basis Robinhood ($HOOD) said a third party had obtained access to email addresses of about 5 mln of its customers, while full names for a different group of nearly 2 mln people in an incident, which took place on Nov. 3; said 310 people had more personal information, including names, birth, dates and zip codes compromised, while 10 customers had more extensive account details revealed Third Coast Bancshares ($TCBX)5M share IPO priced at $25.00

41 Replies 13 ๐Ÿ‘ 13 ๐Ÿ”ฅ

profile
@cespinoza9801 #ivtrades
recently

@Marcosx cris is taking the day off today

74 Replies 6 ๐Ÿ‘ 15 ๐Ÿ”ฅ

profile
@maletone #StockTraders.NET
recently

wow $Cris might see $10s at this rate

61 Replies 10 ๐Ÿ‘ 6 ๐Ÿ”ฅ

BR
@brAli #StockTraders.NET
recently

cris 16 would be nice

60 Replies 15 ๐Ÿ‘ 13 ๐Ÿ”ฅ

profile
@maletone #StockTraders.NET
recently

main watches: $LHDX, $EYES, $CRIS

57 Replies 15 ๐Ÿ‘ 6 ๐Ÿ”ฅ

profile
@TraderXx #StockTraders.NET
recently

same bro.. same > @maletone said: story of my life today but made up for a good portion on $CRIS

136 Replies 10 ๐Ÿ‘ 15 ๐Ÿ”ฅ

profile
@maletone #StockTraders.NET
recently

story of my life today but made up for a good portion on $CRIS

121 Replies 9 ๐Ÿ‘ 6 ๐Ÿ”ฅ

profile
@maletone #StockTraders.NET
recently

covered the remaining bit of $CRIS

111 Replies 7 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@maletone #StockTraders.NET
recently

$LHDX, $EYES, $CRIS $AUTl will be on watch tomorrow

127 Replies 12 ๐Ÿ‘ 11 ๐Ÿ”ฅ

profile
@maletone #StockTraders.NET
recently

feels like $CRIS wants to give up everything

50 Replies 15 ๐Ÿ‘ 12 ๐Ÿ”ฅ

profile
@maletone #StockTraders.NET
recently

$CRIS made my day

69 Replies 12 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@maletone #StockTraders.NET
recently

$CRIS just wowzers

98 Replies 13 ๐Ÿ‘ 12 ๐Ÿ”ฅ

profile
@maletone #StockTraders.NET
recently

$CRIS smashed

97 Replies 9 ๐Ÿ‘ 14 ๐Ÿ”ฅ

XX
@xX_Drip_Gawd_Xx #StockTraders.NET
recently

June 9-17 on calendar for $CRIS

43 Replies 6 ๐Ÿ‘ 12 ๐Ÿ”ฅ

XX
@xX_Drip_Gawd_Xx #StockTraders.NET
recently

Curis (CRIS) shares surged by 63% in afternoon trading after the company said Wednesday it will present updated data in two abstracts for phase 1/2 trial of CA-4948 in treating acute myeloid leukemia and myelodysplastic syndromes. The company is to present the data at the annual meeting of the European Hematology Association, which will be held virtually from **June 9 to June 17**

128 Replies 11 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@maletone #StockTraders.NET
recently

$CRIs looks strong

118 Replies 8 ๐Ÿ‘ 12 ๐Ÿ”ฅ

profile
@maletone #StockTraders.NET
recently

only 200 shares on $CRIS

55 Replies 14 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@maletone #StockTraders.NET
recently

$CRIS goingf

44 Replies 8 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@CarlosH-carvan #ivtrades
recently

1,251 $CRIS 100 19 FEB 21 20 CALL @.43 LMT

67 Replies 6 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@CarlosH-carvan #ivtrades
recently

naaah....C'mon the democrats govern was bad...Carter Iran cris, Obama financial crisis, Clinton Tech bubble

65 Replies 8 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@Armm5 #StockTraders.NET
recently

$CRIS anyone know of any news? this turd jumped on my radar again

147 Replies 6 ๐Ÿ‘ 13 ๐Ÿ”ฅ

profile
@maletone #StockTraders.NET
recently

had an all green week and been on a decent streak since losing on $CRIS..hope this continues going into the new year.

40 Replies 10 ๐Ÿ‘ 8 ๐Ÿ”ฅ

profile
@Armm5 #StockTraders.NET
recently

$CRIS- did offering at $5.75, buyers barely looking up off the table after doing lines

142 Replies 10 ๐Ÿ‘ 15 ๐Ÿ”ฅ

profile
@Counselor #StockTraders.NET
recently

$CRIS is a pure avoid for me. Plenty more low hanging fruit to scoop up.

141 Replies 15 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@Math #StockTraders.NET
recently

out of nowhere $CRIS

130 Replies 6 ๐Ÿ‘ 15 ๐Ÿ”ฅ

profile
@TraderXx #StockTraders.NET
recently

cmon $CRIS CMON!!

70 Replies 8 ๐Ÿ‘ 7 ๐Ÿ”ฅ

profile
@TraderXx #StockTraders.NET
recently

$CRIS holding WAY too well

130 Replies 13 ๐Ÿ‘ 8 ๐Ÿ”ฅ

JO
@jooppp #StockTraders.NET
recently

out $CRIS at 7.35 volume are gone

48 Replies 14 ๐Ÿ‘ 6 ๐Ÿ”ฅ

profile
@maletone #StockTraders.NET
recently

feels like $XBIO will be today's $CRIS

91 Replies 14 ๐Ÿ‘ 14 ๐Ÿ”ฅ

JO
@jooppp #StockTraders.NET
recently

long $CRIS at 7.2

147 Replies 14 ๐Ÿ‘ 13 ๐Ÿ”ฅ

profile
@maletone #StockTraders.NET
recently

$CRIS finally breaking down

64 Replies 10 ๐Ÿ‘ 12 ๐Ÿ”ฅ

ST
@Staci #StockTraders.NET
recently

And CRIS made a higher low!? This chart is not an easy read for me!

112 Replies 15 ๐Ÿ‘ 10 ๐Ÿ”ฅ

ST
@Staci #StockTraders.NET
recently

@maletone for CRIS?

104 Replies 11 ๐Ÿ‘ 11 ๐Ÿ”ฅ

profile
@TraderXx #StockTraders.NET
recently

cmon $CRIS you can do it

149 Replies 12 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@TraderXx #StockTraders.NET
recently

remember guys patience with $CRIS

78 Replies 9 ๐Ÿ‘ 13 ๐Ÿ”ฅ

ZA
@Zamzi #StockTraders.NET
recently

CRIS offering

76 Replies 15 ๐Ÿ‘ 9 ๐Ÿ”ฅ

JO
@jooppp #StockTraders.NET
recently

quit $CRIS at 8.05

141 Replies 14 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@Math #StockTraders.NET
recently

$CRIS s-3 MEF

56 Replies 14 ๐Ÿ‘ 15 ๐Ÿ”ฅ

profile
@Math #StockTraders.NET
recently

$CRIS cancelled previous ATM - and did a 2nd one for same amount

72 Replies 13 ๐Ÿ‘ 12 ๐Ÿ”ฅ

profile
@TraderXx #StockTraders.NET
recently

I have a feeling $CRIS will give another killer opp on the ss side, just be patient

101 Replies 6 ๐Ÿ‘ 8 ๐Ÿ”ฅ

JO
@jooppp #StockTraders.NET
recently

there would be a good price to exit after open $cris

131 Replies 13 ๐Ÿ‘ 12 ๐Ÿ”ฅ

Key Metrics

Market Cap

95.31 M

Beta

0.94

Avg. Volume

4.37 M

Shares Outstanding

91.65 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-02

Next Dividend Date

Company Information

Curis is a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer. In 2015, Curis entered into a collaboration with Aurigene in the areas of immuno-oncology and precision oncology. As part of this collaboration, Curis has exclusive licenses to oral small molecule antagonists of immune checkpoints including the VISTA/PDL1 antagonist CA-170, and the TIM3/PDL1 antagonist CA-327, as well as the IRAK4 kinase inhibitor, CA-4948. CA-4948 is currently undergoing testing in a Phase 1 in patients with non-Hodgkin's lymphoma both as a monotherapy and in combination the with BTK inhibitor ibrutinib. Curis is also evaluating CA-4948 in a Phase 1 trial in patients with acute myeloid leukemia and myelodysplastic syndromes. In addition, Curis is engaged in a collaboration with ImmuNext for development of CI-8993, a monoclonal anti-VISTA antibody, which is currently undergoing testing in a Phase 1a/1b trial in patients with solid tumors. Curis is also party to a collaboration with Genentech, a member of the Roche Group, under which Genentech and Roche are commercializing Erivedgeยฎ for the treatment of advanced basal cell carcinoma.

CEO: James Dentzer

Website:

HQ: 128 Spring Street Lexington, 02421 Massachusetts

Related News